← Back to Screener
agilon health, inc. (AGL)
Price$28.30
Favorite Metrics
Price vs S&P 500 (26W)18.26%
Price vs S&P 500 (4W)172.40%
Market Capitalization$499.01M
All Metrics
Book Value / Share (Quarterly)$0.31
P/TBV (Annual)4.68x
Revenue Growth (3Y)29.87%
Cash Flow / Share (Quarterly)$-0.36
Price vs S&P 500 (YTD)70.37%
Gross Margin (TTM)-0.76%
Net Profit Margin (TTM)-6.60%
EPS (TTM)$-0.94
10-Day Avg Trading Volume0.43M
EPS Excl Extra (TTM)$-0.94
Revenue Growth (5Y)37.25%
EPS (Annual)$-0.95
ROI (Annual)-241.99%
Gross Margin (Annual)-0.76%
Net Profit Margin (5Y Avg)-8.62%
Cash / Share (Quarterly)$0.69
Revenue Growth QoQ (YoY)3.09%
ROA (Last FY)-30.78%
Revenue Growth TTM (YoY)-2.11%
EBITD / Share (TTM)$-0.89
ROE (5Y Avg)-90.24%
Operating Margin (TTM)-7.81%
Cash Flow / Share (Annual)$-0.36
P/B Ratio3.94x
P/B Ratio (Quarterly)2.25x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)0.06x
Net Interest Coverage (TTM)-46.68x
ROA (TTM)-24.03%
EPS Incl Extra (Annual)$-0.95
Current Ratio (Annual)1.02x
Quick Ratio (Quarterly)0.89x
3-Month Avg Trading Volume0.29M
52-Week Price Return-78.03%
Revenue / Employee (TTM)$7
Tangible BV / Share (Quarterly)$0.15
P/S Ratio (Annual)0.08x
Asset Turnover (Annual)4.67x
52-Week High$141.00
Operating Margin (5Y Avg)-8.83%
EPS Excl Extra (Annual)$-0.95
CapEx CAGR (5Y)78.94%
26-Week Price Return27.01%
Quick Ratio (Annual)0.89x
13-Week Price Return24.12%
Total Debt / Equity (Annual)0.28x
Current Ratio (Quarterly)1.02x
Enterprise Value$360.285
Revenue / Share Growth (5Y)35.20%
Asset Turnover (TTM)3.64x
Revenue / Employee (Annual)$7
Pretax Margin (Annual)-6.81%
Cash / Share (Annual)$0.69
3-Month Return Std Dev172.53%
Gross Margin (5Y Avg)6.30%
Net Income / Employee (TTM)$-0
ROE (Last FY)-308.79%
Net Interest Coverage (Annual)-4.39x
EPS Basic Excl Extra (Annual)$-0.95
Receivables Turnover (TTM)7.02x
Total Debt / Equity (Quarterly)0.28x
EPS Incl Extra (TTM)$-0.94
Receivables Turnover (Annual)7.02x
ROI (TTM)-105.64%
P/S Ratio (TTM)0.08x
Pretax Margin (5Y Avg)-8.28%
Revenue / Share (Annual)$14.33
Tangible BV / Share (Annual)$0.15
Price vs S&P 500 (52W)-113.12%
Year-to-Date Return74.51%
5-Day Price Return38.93%
EPS Normalized (Annual)$-0.95
ROA (5Y Avg)-18.55%
Net Profit Margin (Annual)-6.60%
Month-to-Date Return279.90%
Cash Flow / Share (TTM)$-0.17
EBITD / Share (Annual)$-0.89
Operating Margin (Annual)-7.81%
LT Debt / Equity (Annual)0.12x
ROI (5Y Avg)-75.28%
LT Debt / Equity (Quarterly)0.12x
EPS Basic Excl Extra (TTM)$-0.94
P/TBV (Quarterly)4.68x
P/B Ratio (Annual)2.25x
Pretax Margin (TTM)-6.81%
Book Value / Share (Annual)$0.31
Price vs S&P 500 (13W)21.26%
Beta2.24x
Revenue / Share (TTM)$14.31
ROE (TTM)-116.65%
52-Week Low$7.48
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
2.75
2.75
2.75
2.75
Industry Peers — Health Services(14)
| Symbol | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
AGLagilon health, inc. | — | -2.11% | -7.81% | -116.65% | $28.30 |
FMSFresenius Medical Care AG | 11.75x | 1.51% | 9.31% | 7.26% | $23.18 |
DVADaVita Inc. | 13.37x | 6.46% | 14.88% | 181.22% | $149.33 |
SHCSotera Health Company Common Stock | 59.47x | 5.74% | 25.41% | 14.98% | $16.28 |
PGNYProgyny, Inc. Common Stock | 24.25x | 10.40% | 6.62% | 11.37% | $18.64 |
MCTACharming Medical Limited Class A Ordinary Shares | 414.66x | — | 15.45% | — | $29.36 |
VMDViemed Healthcare, Inc. Common Shares | 24.97x | 20.52% | 8.49% | 10.87% | $9.66 |
QIPTQuipt Home Medical Corp. Ordinary Shares | — | 9.52% | -1.22% | -10.47% | $3.65 |
PARKPark Dental Partners, Inc. Common Stock | 17.91x | — | 0.10% | — | $18.25 |
OAKUOak Woods Acquisition Corporation Class A Ordinary Shares | 174.54x | — | — | -0.64% | $12.20 |
OAKUROak Woods Acquisition Corporation Right | 174.54x | — | — | -0.64% | $0.16 |
About
Agilon Health partners with primary care physicians to deliver value-based care to Medicare beneficiaries through a capitated, outcome-focused model. The company's platform enables physician groups to optimize healthcare delivery and reduce costs while maintaining long-term relationships with community-based practices. This model aligns financial incentives between Agilon, physicians, and payors to improve patient outcomes in the senior care market.